4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001104659-25-090207
Chairperson & CEO sold 8,000 shares at an average $400.93 ($3,207,436)
- Chairperson & CEO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,000 | $120.26 | $481,040 | 4,130 | D |
| 2025-09-12 | Sale : show line 2 in the form 10b5-1 | −1,000 | $402.21 | $402,210 | 3,130 | D |
| 2025-09-12 | Sale : show line 3 in the form 10b5-1 | −1,000 | $403.91 | $403,910 | 2,130 | D |
| 2025-09-12 | Sale : show line 4 in the form 10b5-1 | −2,000 | $404.89 | $809,780 | 130 | D |
| 2025-09-15 | Exercise or conversion : show line 5 in the form 10b5-1 | +4,000 | $120.26 | $481,040 | 4,130 | D |
| 2025-09-15 | Sale : show line 6 in the form 10b5-1 | −2,540 | $397.71 | $1,010,180 | 1,590 | D |
| 2025-09-15 | Sale : show line 7 in the form 10b5-1 | −1,460 | $398.19 | $581,356 | 130 | D |
| Open-market sales · 8,000 sh · avg $400.93 · $3,207,436 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-09-12 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −4,000 | $120.26 | 2026-03-15 | 4,000 | 274,000 | D |
| 2025-09-15 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −4,000 | $120.26 | 2026-03-15 | 4,000 | 270,000 | D |
Loading xslF345X05/tm2526183-1_4seq1.xml…